Molotinib treatment indications and medication guidelines

Molotinib, known in English as Momelotinib (also known as Ojjaara), is a new kinase inhibitor developed by GlaxoSmithKline. Due to its excellent therapeutic effect, molotinib has received widespread attention in the medical field. This article will introduce in detail the therapeutic indications of molotinib and the specific methods of administration.

1. Treatment indications

Molotinib is indicated for the treatment of moderate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythemia vera and post-idiopathic thrombocythemia) in adults with anemia. Molotinib addresses the main manifestations of the disease, namely anemia, systemic symptoms, and splenomegaly(splenomegaly).

2. Medication Guide

1. Drug dosage form and recommended dose:

Molotinib is mainly available as oral tablets. The usual starting dose recommendation is 200 mg once daily. However, for patients with severe hepatic impairment (Child-Pugh C grade), the starting dose needs to be adjusted to 150 mg once a day.

2. Medication time and method:

Molotinib can be taken with food or on an empty stomach. When taking this medicine, make sure to swallow the tablets whole and avoid cutting, crushing or chewing the tablets.

3. Treatment of missed doses:

If you miss a dose, there is no need to take it again, you just need to continue taking it at the next normal medication time.

4. Dosage adjustment and physical monitoring:

Physicians will adjust the dose based on the patient's physical response and drug tolerance. Before and during treatment, the doctor will arrange relevant blood tests to monitor the patient's health in real time.

5. Precautions for use:

Patients should always pay attention to their physical condition while taking the medication and promptly report any discomfort or abnormal reactions to their doctor. If overdose is suspected, seek medical assistance immediately.

In short, molotinib, as a cutting-edge therapeutic drug, brings new hope to patients with intermediate and high-risk myelofibrosis. However, correct medication administration and dosage control are crucial to patient efficacy and safety. Therefore, patients must strictly follow their doctor's instructions when taking molotinib. Currently, the price of this drug in overseas markets is about 50,000 yuan per box. Please be sure to purchase it through formal channels and be careful to distinguish the authenticity from the fake.